Stockscreener 앱 받기
16.33
1.62%
0.26
Viatris Inc 주식(VTRS)의 최신 뉴스
Enterprise value to EBITDA forward of Viatris Inc. – NASDAQ:VTRS - TradingView
Viatris interim CFO Paul Campbell sells $809,784 in stock By Investing.com - Investing.com South Africa
Enterprise value to revenue forward of Viatris Inc. – NASDAQ:VTRS - TradingView
Form 4 Viatris Inc For: 26 June By Investing.com - Investing.com Canada
Viatris Inc. stock rises Friday, outperforms market - MarketWatch
Planned sale: Viatris (VTRS) officer disposes 50,076 shares - Stock Titan
Price to sales forward of Viatris Inc. – NASDAQ:VTRS - TradingView
How is Viatris’ stock performance compared to other healthcare stocks? - MSN
Viatris, Inc. Actuals & Estimates (SWB:VIA) - TradingView
Viatris, Inc. Actuals & Estimates (DUS:VIA) - TradingView
Form 144 Viatris Inc For: 25 June By Investing.com - Investing.com Nigeria
Viatris (VTRS) Rule 144 notice lists 49,715 vested shares and other entries - Stock Titan
Viatris Inc. stock rises Wednesday, outperforms market - MarketWatch
How Viatris’ €650 Million Eurobond Issue (VTRS) Has Changed Its Investment Story - simplywall.st
Viatris Inc. stock rises Tuesday, outperforms market - MarketWatch
Viatris Soared 54%: Time To Be More Careful (Rating Downgrade) (NASDAQ:VTRS) - Seeking Alpha
Are Investors Undervaluing Viatris (VTRS) Right Now? - Yahoo Finance
Viatris (VTRS) Q4 2025 Earnings Call Transcript - Fortune
Viatris Inc. (VTRS) Investor Outlook: Is The 15.89% Potential Upside Worth The Risk? - DirectorsTalk Interviews
Come As You Are: Emily Smith Builds Solidarity, Support for LGBTQ+ Colleagues Through VIVID - CSRwire
How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks? - Barchart.com
Viatris Inc. stock falls Thursday, underperforms market - MarketWatch
Viatris Completes €650 Million 4.250% Senior Notes Due 2033 to Refinance 2026 Debt - TradingView
Viatris (NASDAQ: VTRS) issues €650M 4.25% notes to help refinance 2026 debt - Stock Titan
(VTRS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
XS332542958 Bond Price and Chart — FWB:XS332542958 - TradingView
Viatris Inc (VTRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Viatris Inc. stock falls Wednesday, underperforms market - MarketWatch
Viatris Inc (VTRS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Viatris Inc (VTRS) Institutional Confidence - TradingKey
Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch
Viatris Recognized as One of the 2026 Best Workplaces™ in Canada - Yahoo Finance
Viatris launches €650M 4.250% senior notes due 2033 offering - TradingView
Viatris (VTRS) prices €650M 4.250% senior notes maturing 2033 - Stock Titan
Viatris (VTRS) sells €650M 4.25% senior notes to refinance 2026 debt - Stock Titan
Euro Bond Sale Might Change The Case For Investing In Viatris (VTRS) - simplywall.st
Viatris Inc. (VTRS) Stock Analysis: Navigating Growth Prospects with an 8.09% Potential Upside - DirectorsTalk Interviews
Viatris (VTRS) Stock And The 58% Undervaluation Debate After A Strong Year Of Returns - Yahoo Finance
Viatris Euro Debt Raise Reshapes Capital Structure And Valuation Story - Yahoo Finance
Viatris (VTRS) Q1 2026 Earnings Call Transcript - Fortune
[424B5] Viatris Inc Prospectus Supplement (Debt Securities) - Stock Titan
A Look at Viatris Inc (VTRS) After 3.4% Gain -- GF Value $11.01 vs Price $16.31 - GuruFocus
VTRS News | VIATRIS INC (NASDAQ:VTRS) - ChartMill
Viatris Inc. stock rises Thursday, outperforms market - MarketWatch
Viatris Inc. (VTRS) Stock Analysis: Exploring a 13.70% Potential Upside with a Strong Dividend Yield - DirectorsTalk Interviews
Viatris (VTRS) Holds Steady Near Support Amid Flat Trading SessionRSI Overbought Alerts - newsline.com
Liquidity Mapping Around (VTRS) Price Events - Stock Traders Daily
FDA accepts Viatris' NDA for fast-acting non-opioid pain therapy - MSN
Investors brace for Viatris earnings as CFO departure looms By Investing.com - Investing.com Nigeria
Here's Why Viatris (VTRS) is a Strong Value Stock - Yahoo Finance
Salesforce : Agentforce Life Sciences Selected by Viatris as Its Global Customer Engagement Platform - marketscreener.com
Salesforce Agentforce Life Sciences Selected by Viatris as Its Global Customer Engagement Platform - Salesforce
Viatris Inc. stock falls Monday, underperforms market - MarketWatch
Viatris Inc. (VTRS) Stock Analysis: Exploring An 11% Potential Upside Amid Mixed Metrics - DirectorsTalk Interviews
Does FDA Review of Fast-Acting Meloxicam Shift Viatris’ (VTRS) Non-Opioid Pain Strategy? - simplywall.st
2.64%
0.13%
자본화:
|
볼륨(24시간):